Search

Search results

Current filters: HIV, Treatment, HIV drugs

149 search results

Switching to Dovato (dolutegravir + 3TC) from a TAF-based regimen

From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage

Some issues to consider with Dovato (dolutegravir + 3TC)

From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage

Decreasing the risk of neural tube defects with dolutegravir

From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage

Dovato approved in Canada for HIV treatment

2019, CATIE
Research summary - Webpage

Update of recommendations on first- and second-line antiretroviral regimens

2019, World Health Organization (WHO)
Guideline or manual - PDF
More info

Truvada vs. Descovy for HIV prevention

From TreatmentUpdate 231
2019, CATIE
Research summary - Webpage

Can high-dose dolutegravir be a rescue therapy?

From TreatmentUpdate 230
2019, CATIE
Research summary - Webpage

Large French study examines neuropsychiatric side effects with integrase inhibitors

From TreatmentUpdate 230
2019, CATIE
Research summary - Webpage

Higher levels of dolutegravir in older people not linked to side effects

From TreatmentUpdate 230
2019, CATIE
Research summary - Webpage

Delstrigo

2019, CATIE
Fact sheet - Webpage